Locations:
Search
Meet the Director of Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology
Defect in myosin binding may explain why a significant percentage of patients do not adequately respond to anti-TNF therapy
Tools to aid in diagnosis, complication management and lifestyle interventions
Phenylacetylglutamine acts via adrenergic receptors and is linked with cardiac events
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
deepDTnet receives provisional patent to accelerate drug repurposing and minimize the translational gap in development
A mortality risk profile based on lymphocyte count, red blood cell distribution width and C-reactive protein levels
Identifying disease-disease relationships
Noninvasive assessment of carotid artery plaque composition
Capecitabine-based approach shows promise in a population with few options
Epilepsy specialist will bridge research and patient data with clinical care
Advertisement
Advertisement